Charles J. Roberge
Université du Québec
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles J. Roberge.
The Journal of Pathology | 2005
Judith Bellemare; Charles J. Roberge; Danielle Bergeron; Carlos A. Lopez-Vallé; Michel Roy; Véronique J Moulin
Hypertrophic scarring is a pathological process characterized by fibroblastic hyperproliferation and by excessive deposition of extracellular matrix components. It has been hypothesized that abnormalities in epidermal–dermal crosstalk explain this pathology. To test this hypothesis, a tissue‐engineered model of self‐assembled reconstructed skin was used in this study to mimic interactions between dermal and epidermal cells in normal or pathological skin. These skin equivalents were constructed using three dermal cell types: normal wound (Wmyo) or hypertrophic wound (Hmyo) myofibroblasts and normal skin fibroblasts (Fb). Epidermis was reconstructed with normal skin keratinocytes (NK) or hypertrophic scar keratinocytes (HK). In the absence of keratinocytes, Hmyo formed a thicker dermis than Wmyo. When seeded with NK, the dermal thickness of Hmyo (121.2 ± 31.4 µm vs 196.2 ± 27.8 µm) and Fb (43.7 ± 7.1 µm vs 83.6 ± 16.3 µm) dermis was significantly (p < 0.05) reduced, while that of Wmyo (201.5 ± 15.7 µm vs 160.7 ± 21.1 µm) was increased. However, the presence of HK always induced significantly thicker dermis formation than observed with NK (Wmyo: 238.8 ± 25.9 µm; Hmyo: 145.5 ± 22.4 µm; Fb: 74.2 ± 11.2 µm). These results correlated with collagen and MMP‐1 secretion and with cell proliferation, which were increased when keratinocytes were added, except for the collagen secretion of Hmyo and Fb in the presence of NK. The level of dermal apoptosis was not different when epidermis was added to the dermis (<1% in each category). These observations strongly suggest that hypertrophic scar keratinocytes play a role in the development of pathological fibrosis by influencing the behaviour of dermal cells. Copyright
Journal of Leukocyte Biology | 2001
Martin Pelletier; Charles J. Roberge; Marc Gauthier; Karen Vandal; Philippe A. Tessier; Denis Girard
Many chemicals of environmental concern are known to alter the immune system and are considered toxic molecules because they affect immune cell functions. Inflammation related to environmental chemical exposure, however, is poorly documented, except that from air pollutants. In this study, we found that the organochlorine insecticide dieldrin could not alter the ability of human neutrophils to phagocytose opsonized sheep red blood cells at nonnecrotic concentrations (0.1, 1, 10, and 50 μM). However, dieldrin was found to increase human neutrophil superoxide production, RNA synthesis, and proinflammatory cytokine interleukin‐8 production. The normal apoptotic rate of neutrophils evaluated by both cytology and flow cytometry (CD‐16 staining) was not altered by dieldrin treatments, and this was correlated with its inability to inhibit spreading of neutrophils onto glass. Using the murine air pouch model, we found that dieldrin induces a neutrophilic inflammation. Taken together, these results demonstrated that dieldrin is a proinflammatory contaminant. To our knowledge, this is the first report establishing that dieldrin is a contaminant exhibiting proinflammatory properties. In addition, it is the first time that the murine air pouch model has been successfully used to confirm that a chemical of environmental concern can induce an inflammatory response in vivo.
Clinical Immunology | 2002
Claude Ratthé; Martin Pelletier; Charles J. Roberge; Denis Girard
Clinical Immunology | 2001
Marc Gauthier; Charles J. Roberge; Martin Pelletier; Philippe A. Tessier; Denis Girard
Clinical Immunology | 2002
Valérie Lavastre; Charles J. Roberge; Martin Pelletier; Marc Gauthier; Denis Girard
Tissue Engineering Part A | 2010
Jean Dubé; Olivier Rochette-Drouin; Philippe Lévesque; Robert Gauvin; Charles J. Roberge; François A. Auger; Daniel Goulet; Michel Bourdages; Michel Plante; Lucie Germain; Véronique Moulin
Archive | 2003
Lucie Germain; François A. Auger; François Bergeron; Charles J. Roberge
Advances in wound care | 2012
Véronique Moulin; Jean Dubé; Olivier Rochette-Drouin; Philippe Lévesque; Robert Gauvin; Charles J. Roberge; François A. Auger; Daniel Goulet; Michel Bourdages; Michel Plante; Lucie Germain
Archive | 2003
François A. Auger; François Bergeron; Lucie Germain; Charles J. Roberge
Archive | 2002
Hugues Lafrance; François Bergeron; Charles J. Roberge; Lucie Germain; François A. Auger